PRN_KbroVet Educational_Promo_eblast
Subject line(s)
Seize the Day: New Pharmaceutical Options for Idiopathic Epilepsy
Preview Text
Conditionally Approved Drug for the Epileptic Patient
#5c2e84
#4d4e4e
{{custommediaemailsadvanced::eyebrow_copy}}
{{custommediaemailsadvanced::eyebrow_background_color}}
{{custommediaemailsadvanced::eyebrow_text_color}}
{{custommediaemailsadvanced::is_partner_podcast}}
Or listen on your favorite{nbs}platform:
{{custommediaemailsadvanced::partner_podcast_spotify_url}}
{{custommediaemailsadvanced::partner_podcast_apple_url}}
{{custommediaemailsadvanced::partner_podcast_google_url}}
/uploads/p_r_n_k_bro_v_et_artboard_79_2_x-27fa0106590d868ae3fcb8c49ff22af9.png
{{custommediaemailsadvanced::logo_self_hosted}}
99
{{custommediaemailsadvanced::logo_height}}
{{custommediaemailsadvanced::logo_padding}}
{{custommediaemailsadvanced::logo_alt_text}}
{{custommediaemailsadvanced::logo_url}}
{{custommediaemailsadvanced::no_border_under_logo}}
{{custommediaemailsadvanced::apply_logo_over_background_image}}
true
/uploads/p_r_n_k_bro_v_et_header_2_x-3e0fbee14497751ad7e2b73a91b4477c.jpg
{{custommediaemailsadvanced::desktop_header_image_alt}}
{{custommediaemailsadvanced::desktop_header_image_alt_1x}}
true
true
{{custommediaemailsadvanced::mobile_header_image}}
{{custommediaemailsadvanced::mobile_header_image_alt}}
{{custommediaemailsadvanced::add_left_right_padding_to_header_image}}
{{custommediaemailsadvanced::add_bottom_padding_to_header_image}}
{{custommediaemailsadvanced::add_top_padding_to_header_image}}
{{custommediaemailsadvanced::header_image_padding_background_color}}
{{custommediaemailsadvanced::scale_mobile_header_image}}
{{custommediaemailsadvanced::background_height}}
#000000
{{custommediaemailsadvanced::headline_image}}
{{custommediaemailsadvanced::headline_image_self_hosted}}
{{custommediaemailsadvanced::headline_url}}
480
379
{{custommediaemailsadvanced::headline_image_custom_css}}
{{custommediaemailsadvanced::place_headline_image_above_header_image}}
{{custommediaemailsadvanced::place_headline_image_below_header_image}}
{{custommediaemailsadvanced::spacer_image}}
{{custommediaemailsadvanced::spacer_image_self_hosted}}
600
{{custommediaemailsadvanced::spacer_image_height}}
{{custommediaemailsadvanced::spacer_image_scale_desktop_padding_bottom}}
{{custommediaemailsadvanced::spacer_image_scale_mobile_padding_bottom}}
{{custommediaemailsadvanced::subhead_copy}}
{{custommediaemailsadvanced::large_subhead_copy}}
{{custommediaemailsadvanced::subhead_td_custom_css}}
{{custommediaemailsadvanced::subhead_span_custom_css}}
{{custommediaemailsadvanced::horizontal_rule_under_subhead}}
{{custommediaemailsadvanced::intro_copy}}
{{custommediaemailsadvanced::intro_centered}}
{{custommediaemailsadvanced::intro_copy_td_custom_css}}
{{custommediaemailsadvanced::intro_copy_span_custom_css}}
{{custommediaemailsadvanced::horizontal_rule_under_intro}}
Finding a safe and effective treatment protocol for dogs with seizures can often serve up a challenge for the veterinary practitioner. KBroVet®-CA1 is a conditionally approved, flavored, chewable tablet for the treatment of idiopathic epilepsy in dogs, with a proven safety record from the FDA.
{{custommediaemailsadvanced::custom_body_text_color}}
{{custommediaemailsadvanced::custom_body_background_color}}
text-align: center; padding-top: 10px;
{{custommediaemailsadvanced::body_span_custom_css}}
{{custommediaemailsadvanced::custom_body_horizontal_rule_color}}
{{custommediaemailsadvanced::ordered_list_bullet_1}}
1
{{custommediaemailsadvanced::custom_icon_1}}
{{custommediaemailsadvanced::custom_icon_1_self_hosted}}
{{custommediaemailsadvanced::custom_icon_1_width}}
{{custommediaemailsadvanced::ordered_list_bullet_2}}
2
{{custommediaemailsadvanced::custom_icon_2}}
{{custommediaemailsadvanced::custom_icon_2_self_hosted}}
{{custommediaemailsadvanced::custom_icon_2_width}}
{{custommediaemailsadvanced::ordered_list_bullet_3}}
3
{{custommediaemailsadvanced::custom_icon_3}}
{{custommediaemailsadvanced::custom_icon_3_self_hosted}}
{{custommediaemailsadvanced::custom_icon_3_width}}
{{custommediaemailsadvanced::ordered_list_bullet_4}}
4
{{custommediaemailsadvanced::custom_icon_4}}
{{custommediaemailsadvanced::custom_icon_4_self_hosted}}
{{custommediaemailsadvanced::custom_icon_4_width}}
{{custommediaemailsadvanced::ordered_list_bullet_5}}
5
{{custommediaemailsadvanced::custom_icon_5}}
{{custommediaemailsadvanced::custom_icon_5_self_hosted}}
{{custommediaemailsadvanced::custom_icon_5_width}}
#000000
{{custommediaemailsadvanced::center_icons_in_mobile}}
{{custommediaemailsadvanced::ordered_list_bullet_td_custom_css}}
{{custommediaemailsadvanced::ordered_list_bullet_span_custom_css}}
{{custommediaemailsadvanced::body_2_copy}}
{{custommediaemailsadvanced::body_2_td_custom_css}}
{{custommediaemailsadvanced::body_2_span_custom_css}}
{{custommediaemailsadvanced::closing_emphasis_copy}}
{{custommediaemailsadvanced::closing_emphasis_link_text}}
{{custommediaemailsadvanced::closing_emphasis_link_url}}
{{custommediaemailsadvanced::closing_emphasis_link_color}}
{{custommediaemailsadvanced::closing_emphasis_td_custom_css}}
{{custommediaemailsadvanced::closing_emphasis_span_custom_css}}
background-color: #4d4e4e;
Learn how conditionally approved{br}drugs can benefit veterinary{br}patients without sacrificing{nbs}safety.
{{custommediaemailsadvanced::cta_line_1_custom_text_color}}
true
{{custommediaemailsadvanced::cta_line_2}}
{{custommediaemailsadvanced::cta_line_2_custom_text_color}}
{{custommediaemailsadvanced::cta_line_2_link}}
Read More Now
#5c2e84
{{custommediaemailsadvanced::custom_button_text_color}}
https://www.cliniciansbrief.com/article/fda-conditional-approval-what-does-it-mean-what-should-veterinarians-know
{{custommediaemailsadvanced::footnote}}
{{custommediaemailsadvanced::large_footnote_copy}}
{{custommediaemailsadvanced::footnote_td_custom_css}}
{{custommediaemailsadvanced::footnote_span_custom_css}}
{{custommediaemailsadvanced::pre_footer_copy}}
{{custommediaemailsadvanced::pre_footer_center}}
Conditionally Approved Drug for the Epileptic Patient
</head>
<body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
Conditionally Approved Drug for the Epileptic Patient